about
Plant-made oral vaccines against human infectious diseases-Are we there yet?Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionNanoparticle transport from mouse vagina to adjacent lymph nodesUltradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis AntigensNovel viral vectored vaccines for the prevention of influenza.Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsThe A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigensLow dose antigen exposure for a finite period in newborn rats prevents induction of mucosal toleranceVibrio cholerae: lessons for mucosal vaccine design.Oral antigen exposure in extreme early life in lambs influences the magnitude of the immune response which can be generated in later life.Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationFlagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer.Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract.Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective.Optimizing efficacy of mucosal vaccines.Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.An oral microjet vaccination system elicits antibody production in rabbits.Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.Generation of assay positive controls for detection of isotype anti-drug antibodies for immunogenicity monitoring.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis Against Enterotoxigenic Escherichia coli Infection
P2860
Q26783111-B6B70D0E-1147-4EB2-8E34-8777359E1056Q27001897-4E978FDC-0E37-4B9A-9307-69EC5CA8F63EQ27329123-A810C49C-F8E8-455F-8D93-6B17C806034DQ28550483-9637F14E-6F7B-41FB-8708-1B4AC1FC1252Q30418570-3CF5EF4D-AEAA-43A8-9D77-DA98DF7EF502Q33862822-9989FEBC-3DAA-489D-BF4E-B1F99C4679A8Q34270342-784FE1E8-287B-480A-AA78-C8CD60C48975Q34516644-DA6F5965-CFAC-4A7B-8205-22733B6710D0Q34562952-242211A8-C545-4F23-B321-65E9B3A60551Q34928859-80034A04-5392-43B8-8476-C6561B70408BQ35170057-BB57DAAF-17BA-426F-B361-8F0AADB5095BQ36598433-1D7FA787-5AA3-443E-A99C-53049F253CBDQ36711018-783F489E-536F-4823-B2D8-FE84EDD0A55CQ36735275-1418CA97-8EB3-415B-A4D0-A32B51EAF217Q37876027-2F74E431-FF04-4F44-8DFB-20B9D4ED79A6Q38020309-084E2C31-ED9C-494D-BE18-C4057E97F887Q38059754-078CFB95-8DD8-4B63-A3BE-6D2BC81C642EQ38335733-4AF63C00-A4D1-4BE3-9579-4A7B6D65C5EBQ38618893-A203C1D5-6A2D-4088-BFF1-EC0900F47C84Q38650844-8700A2E1-C703-43DE-AC3E-37F3B33FD087Q38765335-E8180AC0-3287-4FB0-B83D-0DFA61A9B079Q41184340-B2AC3E6D-64C5-417E-99F1-B1FE33D179CBQ42045167-993E403A-FA4F-44E1-88BB-BD9FC3FF9291Q42723998-B64403E6-939B-40A5-8CA9-B82B77F6DF2AQ43876810-EEBF0B6E-DF39-4CD3-B46E-13471C628F40Q47408496-2D556049-4394-4043-8FAD-63A362CB5BF1Q52725104-D28AD5E3-D26D-404D-A13F-5CAE61076D25Q57952623-39DAE779-B4A2-4277-BACB-70ABF8EEC3C6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Topical immunization strategies.
@en
Topical immunization strategies.
@nl
type
label
Topical immunization strategies.
@en
Topical immunization strategies.
@nl
prefLabel
Topical immunization strategies.
@en
Topical immunization strategies.
@nl
P2860
P356
P1433
P1476
Topical immunization strategies.
@en
P2093
C Czerkinsky
P2860
P2888
P304
P356
10.1038/MI.2010.55
P50
P577
2010-09-22T00:00:00Z